ArticleMolecular cancer therapeutics2026

TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies.

Yuka Hoshi-Kadonosawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.